Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Thomas E Adrian Author

Subjects of specialization
Pancreatic cancer, Apoptosis, Proliferation, Troleandomycin

Affiliation
Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE

Biography

Thomas E Adrian was working in the Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE. He has more than 30 publications. His research work related to apoptosis.


Publications

Research Article Open Access

Inhibition of Cytochrome P450 and Multidrug Resistance Proteins Potentiates the Efficacy of All-Trans Retinoic Acid in Pancreatic Cancer In Vitro and In Vivo

Author(s):

Taghrid B El-Abaseri, Tarek H El- Metwally, Patrick L Iversen and Thomas E Adrian

Objectives: All-trans retinoic acid (atRA) potently induces differentiation and apoptosis in pancreatic cancer. However, the clinical use of retinoids is limited by retinoid resistance or development of toxicity at high doses. We tested the hypothesis that blocking atRA degradation and elimination from the cell would potentiate its effectiveness in pancreatic cancer therapy.

Methods: In vitro, AsPc-1 and HPAF cells were co-treated with atRA and inhibitors of either multidrug resistance (MDR: verapamil, LY335979, and quinidine) or cytochrome P450 (CYP450s: troleandomycin, clotrimazole and liarozole). In addition, cells were co treated with atRA and antisense view moreĀ»

DOI: 10.4172/2324-9110.1000138

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP